Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice

Journal of Hepatology

Volumn 45, Issue 1, 2006, Pages 20-27

  Teoh, Narci ^a   Field, Jacqueline ^a   Farrell, Geoffrey ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cell cycle; Hepatic ischaemia reperfusion injury; Interleukin 6; Ischaemic preconditioning; Nuclear factor kappa B; Signal transducer and activator of transcription 3; Tumour necrosis factor

Indexed keywords

RECOMBINANT INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL CYCLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; ISCHEMIC PRECONDITIONING; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REPERFUSION INJURY; WILD TYPE;

EID: 33744941349     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.01.039     Document Type: Article

References (40)

1. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) G15-G26
2. Teoh N., and Farrell G.C. Hepatic ischaemia reperfusion injury. Pathogenic mechanisms and basis for protection. J Gastroenterol Hepatol 18 (2003) 891-902
3. Jaeschke H., Farhood A., and Smith C.W. Neutrophils contribute to ischemia-reperfusion injury in rat liver in vivo. Fed Am Soc Exp Biol J 4 (1990) 3355-3359
4. Jaeschke H., Farhood A., and Bautista A.P. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol Gastrointest Liver Physiol 264 (1993) G801-G809
5. Colletti L., Remick D.G., Burtch G.D., Kunkel S.L., Strieter R.M., and Campbell Jr. D.A. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85 (1990) 1936-1943
6. Rudiger H.A., and Clavien P. Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122 (2002) 202-210
7. Teoh N., Leclercq I., dela Pena A., and Farrell G. Low dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 37 (2003) 118-128
8. Teoh N., Field J., Sutton J., and Farrell G. Dual role of tumor necrosis factor-α in hepatic ischemia reperfusion injury: studies in tumor necrosis factor-α gene knockout mice. Hepatology 39 (2004) 412-421
9. Peralta C., Prats N., Xaus C., Gelpi E., and Rosello-Catafau J. Protective effect of liver preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 30 (1999) 1481-1489
10. Clavien P.A., Yadav S., Sindram D., and Bentley R.C. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232 (2000) 163-165
11. Teoh N., dela Pena A., and Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase and cell cycle entry. Hepatology 36 (2002) 94-102
12. Clavien P.A., Selzner M., Rudiger H.A., Graf R., Kadry Z., Rousson V., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238 (2003) 843-850
13. Brenner D.A. Signal transduction during liver regeneration. J Gastroenterol Hepatol 13 (1998) S93-S95
14. Fausto N. Liver regeneration. J Hepatol 32 (2000) 19-31
15. Yamada Y., Kirillova I., Peschon J.J., and Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor. Proc Natl Acad Sci USA 94 (1997) 1441-1446
16. Webber E.M., Bruix J., Pierce R.H., and Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28 (1998) 1226-1234
17. Xu Y., Jones B.E., Neufeld D., and Czaja M. Glutathione modulates rat and mouse hepatocyte sensitivity to tumour necrosis factor α toxicity. Gastroenterology 115 (1998) 1229-1237
18. Cressman D.E., Greenbaum L.E., Haber B., and Taub R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 269 (1994) 30429-30435
19. Fitzgerald M.J., Webber E.M., Donovan J.R., and Fausto N. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ 6 (1995) 417-427
20. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996) 1379-1383
21. Yamada Y., Webber E.M., Kirillova I., Peschon J.J., and Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28 (1998) 959-970
22. Selzner N., Selzner M., Tian Y., Kadry Z., and Clavien P.A. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-alpha/IL-6 -dependent mechanism. Hepatology 36 (2002) 812-818
23. Camargo C.A., Madden J.F., Gao W., Selvan R., and Clavien P. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26 (1997) 1513-1520
24. Selzner M., Camargo C.A., and Clavien P.A. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 30 (1999) 469-475
25. Sun Z., Klein A.S., Radaeva S., Hong F., El-Assal O., Pan H., et al. In vitro interleukin-6 prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125 (2003) 202-215
26. Hong F., Radaeva S., Pan H., Tian Z., Veech R., and Gao B. Interleukin-6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40 (2004) 933-941
27. Essani N.A., McGuire G.M., Manning A.M., and Jaeschke H. Endotoxin-induced activation of nuclear factor transcription factor-κB and expression of E-selectin messenger RNA in hepatocytes, kupffer cells, and endothelial cells in vivo. J Immunology 156 (1996) 2956-2963
28. Blindenbacher A., Wang X., Langer I., Savino R., Terracciano L., and Heim M.H. Interleukin-6 is important for survival after partial hepatectomy in mice. Hepatology 38 (2003) 674-682
29. Wuestefeld T., Klein C., Streetz K., Betz U., Laugers J., Buers J., et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278 (2003) 11281-11288
30. Guidi L., Tricerri A., Costanzo M., Adducci E., Ciarnello M., Errani A.R., et al. Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans. Dig Liver Dis 35 (2003) 409-415
31. Cressman D.E., Diamond R.H., and Taub R. Rapid activation of the STAT3 transcription factor complex in liver regeneration. Hepatology 21 (1995) 1443-1449
32. Serafin A., Rosello-Catafau J., Prats N., Gelpi E., Rodes J., and Peralta C. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39 (2004) 688-698
33. Taub R. Hepatoprotection via the IL-6/STAT3 pathway. J Clin Invest 112 (2003) 978-980
34. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 (2000) 2548-2556
35. Vajdova K., Heinreich S., Tian Y., Graf R., and Clavien P. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and kupffer cell function after ischemic injury. Liver Transpl 10 (2004) 520-528
36. Debonera F., Aldeguer X., Shen X., Gelman A., Gao F., Que X., et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J Surg Res 96 (2001) 289-295
37. Leclercq I., Field J., and Farrell G.C. Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124 (2003) 1451-1464
38. Wustefeld T., Rakemann T., Kubicka S., Manns M.P., and Trautwein C. Hyperstimulation with interleukin-6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 32 (2000) 514-522
39. Veldhuis G., Willemse P., Mulder N., Limburg P., and De Vries E. Potential use of recombinant human interleukin-6 in clinical oncology. Leuk Lymphoma 20 (1996) 673-679
40. Tate J., Olencki T., Finke J., Kottke-Marchant K., Rybicki L., and Phase I. Phase I trial of simultaneous administration of GM-CSF and IL-6 in patients with renal cell carcinoma: clinical and laboratory effects. Ann Oncol 12 (2001) 655-659